Kings Path Partners LLC Adma Biologics, Inc. Transaction History
Kings Path Partners LLC
- $248 Billion
- Q2 2025
A detailed history of Kings Path Partners LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Kings Path Partners LLC holds 28,940 shares of ADMA stock, worth $517,447. This represents 0.21% of its overall portfolio holdings.
Number of Shares
28,940
Previous 21,425
35.08%
Holding current value
$517,447
Previous $425 Million
23.98%
% of portfolio
0.21%
Previous 0.21%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
382Shares Held
187MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$333 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$301 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$230 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$205 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$101 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.51B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...